Scone Medical Solutions Inc Announces Issuance of U.S. Patent for Self-Contained Negative Pressure Environment
Patent 10,967,204 is directed toward the use of negative pressure in a small-capacity barrier protection device that actively removes airborne particulates emitted around a patient\'s upper torso.
- Patent 10,967,204 is directed toward the use of negative pressure in a small-capacity barrier protection device that actively removes airborne particulates emitted around a patient\'s upper torso.
- The Self-Contained Negative Pressure Environment (SCONE) prevents exposure to pathogenic airborne particulates during triage and transportation, and treatments, including aerosol-generating procedures (AGPs) and end-of-life care.
- The SCONE system is a collapsible device with a flexible cover with arm access holes for medical professionals to reach in and treat patients by performing various procedures.
- The SCONE device was Authorized for Emergency Use by the FDA on December 18, 2020 and is in the process of applying for full FDA approval.\n"We are extremely pleased to receive a newly-issued Patent for our Self-Contained Negative Pressure Environment (SCONE) device.